niacinamide has been researched along with interleukin-8 in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (50.00) | 29.6817 |
2010's | 7 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boerman, OC; Corstens, FH; Koenders, EB; Oyen, WJ; Rennen, HJ | 1 |
Bröcker, EB; Kruse, N; Reimer, S; Schmidt, E; Zillikens, D | 1 |
Boerman, OC; Corstens, FH; Gratz, S; Oyen, WJ; Rennen, HJ | 1 |
Cutshall, NS; Ihle, NC; Kucera, KA; Latham, J; Ursino, R | 1 |
Blömback, M; Söderström, T; Ungerstedt, JS | 1 |
Barnes, PJ; Catley, MC; Holden, NS; Leigh, R; Newton, R; Oyelusi, W; Proud, D | 1 |
Calvez, V; Dupin, N; Grange, PA; Raingeaud, J | 1 |
Bertolotto, C; Bourcier, C; Grépin, R; Griseri, P; Mazure, N; Pagès, G | 1 |
Hau, CS; Kanda, N; Sato, S; Tada, Y; Tatsuta, A; Watanabe, S | 1 |
Coelho, MM; Duarte, ID; Ferreira, RG; Godin, AM; Gomides, LF; Klein, A; Matsui, TC; Menezes, GB; Pereira-Silva, PE | 1 |
Fan, GH; Kirpotina, LN; Maeda, DY; Peck, AM; Quinn, MT; Schuler, AD; Wicomb, WN; Zebala, JA | 1 |
Fedorkiv, MB | 1 |
Biancheri, P; Foster, MR; Fyfe, MC; MacDonald, TT; Rowley, A; Sirohi, S; Solanke, Y; Walshe, CA; Webber, S; Wood, E | 1 |
Buharalioglu, CK; Cil, M; Guden, DS; Korkmaz, B; Malik, KU; Sahan-Firat, S; Sari, AN; Senol, SP; Temiz-Resitoglu, M; Tunctan, B; Unsal, D | 1 |
14 other study(ies) available for niacinamide and interleukin-8
Article | Year |
---|---|
Labeling proteins with Tc-99m via hydrazinonicotinamide (HYNIC): optimization of the conjugation reaction.
Topics: Aprotinin; Biological Assay; Chromatography, High Pressure Liquid; Cytochrome c Group; Humans; Hydrazines; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-8; Lactalbumin; Leukocytes; Muramidase; Niacinamide; Proteins; Receptors, Immunologic; Sialoglycoproteins; Technetium | 2000 |
The IL-8 release from cultured human keratinocytes, mediated by antibodies to bullous pemphigoid autoantigen 180, is inhibited by dapsone.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Autoantibodies; Autoantigens; Cells, Cultured; Chemotaxis, Leukocyte; Collagen Type XVII; Dapsone; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Humans; Immunoglobulin G; Interleukin-6; Interleukin-8; Keratinocytes; Neutrophil Infiltration; Niacinamide; Non-Fibrillar Collagens; Pemphigoid, Bullous; Rabbits; RNA, Messenger | 2001 |
Rapid imaging of experimental colitis with (99m)Tc-interleukin-8 in rabbits.
Topics: Acute Disease; Animals; Colitis; Colon; Female; Gamma Cameras; Granulocytes; Hydrazines; Interleukin-8; Niacinamide; Rabbits; Radionuclide Imaging; Radiopharmaceuticals; Technetium; Technetium Tc 99m Exametazime; Trinitrobenzenesulfonic Acid | 2001 |
Nicotinamide N-oxides as CXCR2 antagonists.
Topics: Autoimmune Diseases; Binding Sites; Chemokine CXCL1; Chemokines, CXC; Chemotactic Factors; Chemotaxis; Growth Substances; Humans; Hypersensitivity; Inflammation; Inhibitory Concentration 50; Intercellular Signaling Peptides and Proteins; Interleukin-8; Neutrophils; Niacinamide; Protein Binding; Receptors, Interleukin-8B; Structure-Activity Relationship | 2001 |
Nicotinamide is a potent inhibitor of proinflammatory cytokines.
Topics: Adjuvants, Immunologic; Cells, Cultured; Cytokines; Depression, Chemical; Dose-Response Relationship, Drug; Endotoxemia; Enzyme Inhibitors; Humans; Interleukin-1; Interleukin-6; Interleukin-8; Niacinamide; Phenanthrenes; Poly Adenosine Diphosphate Ribose; Tumor Necrosis Factor-alpha | 2003 |
Repression of inflammatory gene expression in human pulmonary epithelial cells by small-molecule IkappaB kinase inhibitors.
Topics: Carbolines; Cells, Cultured; Cytokines; Epithelial Cells; Gene Expression Regulation; Heterocyclic Compounds, 3-Ring; Humans; I-kappa B Kinase; Interleukin-1beta; Interleukin-6; Interleukin-8; Lung; NF-kappa B; Niacinamide; Protein Kinase Inhibitors; Pulmonary Disease, Chronic Obstructive; Pyridines; Transcription, Genetic; Tumor Necrosis Factor-alpha | 2007 |
Nicotinamide inhibits Propionibacterium acnes-induced IL-8 production in keratinocytes through the NF-kappaB and MAPK pathways.
Topics: Anti-Inflammatory Agents; Blotting, Western; Cell Line; Dermatologic Agents; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Extracellular Signal-Regulated MAP Kinases; Humans; I-kappa B Proteins; Immunity, Innate; Interleukin-8; JNK Mitogen-Activated Protein Kinases; Keratinocytes; MAP Kinase Signaling System; NF-kappa B; Niacinamide; Phosphorylation; Promoter Regions, Genetic; Propionibacterium acnes; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Transcriptional Activation; Transfection | 2009 |
Constitutive ERK activity induces downregulation of tristetraprolin, a major protein controlling interleukin8/CXCL8 mRNA stability in melanoma cells.
Topics: Animals; Antibodies; Antineoplastic Agents; Apoptosis; Autophagy; Benzamides; Benzenesulfonates; Cell Line, Tumor; Cell Proliferation; Chemokine CXCL1; Chemokine CXCL5; Dichlororibofuranosylbenzimidazole; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression; Genes, Reporter; Half-Life; Humans; Immunotherapy, Active; Interleukin-8; Leupeptins; MAP Kinase Kinase Kinases; Melanoma; Membrane Proteins; Mice; Mice, Inbred BALB C; Microtubule-Associated Proteins; Niacinamide; Phenylurea Compounds; Phosphorylation; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Proto-Oncogene Proteins; Pyridines; Receptors, Interleukin-8B; RNA Stability; RNA, Messenger; RNA, Small Interfering; Sorafenib; Transfection; Tristetraprolin; Tumor Cells, Cultured; Vaccination | 2011 |
Visfatin enhances CXCL8, CXCL10, and CCL20 production in human keratinocytes.
Topics: Animals; Cells, Cultured; Chemokine CCL20; Chemokine CXCL10; Female; Humans; I-kappa B Kinase; Interleukin-8; Janus Kinase 2; Keratinocytes; Mice; Mice, Inbred BALB C; NF-kappa B; Niacinamide; Nicotinamide Phosphoribosyltransferase; Pentosyltransferases; Psoriasis; Receptor, Insulin; STAT3 Transcription Factor; Tumor Necrosis Factor-alpha | 2011 |
Neutrophil recruitment is inhibited by nicotinamide in experimental pleurisy in mice.
Topics: Animals; Anti-Inflammatory Agents; Carrageenan; Cell Adhesion; Disease Models, Animal; Interleukin-8; Leukocyte Rolling; Leukotriene B4; Male; Mice; Mice, Inbred BALB C; Neutrophil Infiltration; Niacinamide; Pleurisy | 2012 |
Discovery of 2-[5-(4-Fluorophenylcarbamoyl)pyridin-2-ylsulfanylmethyl]phenylboronic Acid (SX-517): Noncompetitive Boronic Acid Antagonist of CXCR1 and CXCR2.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Binding, Competitive; Boronic Acids; Chemokine CXCL1; Combinatorial Chemistry Techniques; HEK293 Cells; Humans; Inflammation; Interleukin-8; Male; MAP Kinase Signaling System; Mice, Inbred Strains; Neutrophils; Niacinamide; Phosphorylation; Receptors, Interleukin-8A; Receptors, Interleukin-8B; Structure-Activity Relationship | 2014 |
[PREVENTION AND CORRECTION OF PULMONARY COMPLICATIONS FOR SEVERE ACUTE PANCREATITIS].
Topics: Acute Disease; Acute Lung Injury; Adult; Aged; Antioxidants; Capillary Permeability; Diaphragm; Drug Combinations; Exudates and Transudates; Female; Flavin Mononucleotide; Fluid Therapy; Humans; Inosine Diphosphate; Interleukin-8; Lipid Peroxidation; Lung; Male; Middle Aged; Niacinamide; Pancreas; Pancreatitis; Peritoneum; Pleura; Protective Agents; Succinates; Tumor Necrosis Factor-alpha; Vasodilation | 2015 |
Effect of Narrow Spectrum Versus Selective Kinase Inhibitors on the Intestinal Proinflammatory Immune Response in Ulcerative Colitis.
Topics: Benzamides; Biopsy; Colitis, Ulcerative; Cytokines; Dasatinib; HT29 Cells; Humans; Interleukin-8; Leukocytes, Mononuclear; Macrophages; Mitogen-Activated Protein Kinase 14; Myofibroblasts; Naphthalenes; Niacinamide; Primary Cell Culture; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; src-Family Kinases; Syk Kinase | 2016 |
NF-κB activation mediates LPS-or zymosan-induced hypotension and inflammation reversed by BAY61-3606, a selective Syk inhibitor, in rat models of septic and non-septic shock.
Topics: Animals; Cyclooxygenase 2; Disease Models, Animal; Gene Expression Regulation; Gene Expression Regulation, Enzymologic; Hypotension; Inflammation; Interleukin-8; Lipopolysaccharides; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Niacinamide; Nitric Oxide Synthase Type II; Protein Kinase Inhibitors; Pyrimidines; Rats; Rats, Wistar; Shock, Septic; Syk Kinase; Tumor Necrosis Factor-alpha; Zymosan | 2019 |